Skip to main content
Joseph Antin, MD, Hematology, Boston, MA

Joseph Harry Antin MD

Hematologic Oncology


Professor of Medicine, Dana-Farber Cancer Institute

Join to View Full Profile
  • 44 Binney St# Dana-FarBoston, MA 02115

  • Phone+1 617-632-3667

  • Fax+1 617-632-5175

Dr. Antin is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Education & Training

  • Mass General Brigham/Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer Institute
    Mass General Brigham/Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer InstituteFellowship, Hematology and Medical Oncology, 1981 - 1983
  • Mass General Brigham/Brigham and Women's Hospital
    Mass General Brigham/Brigham and Women's HospitalResidency, Internal Medicine, 1978 - 1981
  • Weill Cornell Medicine
    Weill Cornell MedicineClass of 1978

Certifications & Licensure

  • MA State Medical License
    MA State Medical License 1986 - 2025
  • Internal Medicine
    American Board of Internal Medicine Internal Medicine
  • Hematology
    American Board of Internal Medicine Hematology
  • Medical Oncology
    American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

  • Boston Magazine Castle Connolly, 2008-2013
  • America's Top Doctors for Cancer Castle Connolly, 2005-2013
  • Boston Herald Castle Connolly, 2005
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Small-Molecule BCL6 Inhibitor Effectively Treats Mice with Non-Sclerodermatous Chronic Graft-Versus-Host Disease  
    Joseph H Antin, Bruce Blazar, Leo Luznik, John Koreth, Ivan Maillard, Robert J Soiffer, James E Bradner, Jonathan S Serody, Jerome Ritz, Blood

Abstracts/Posters

  • Improved Outcomes with Cyclophosphamide/Total Body Irradiation 14 Gy Compared to Cyclophosphamide/Total Body Irradiation 12 Gy in Patients with Acute Lymphoblastic Leu...
    Joseph H. Antin, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
  • Anti-CD6 Monoclonal Antibody Itolizumab Efficiently Inhibits T Cell Proliferation after in Vitro TCR Stimulation in the Setting of Acute Graft Versus Host Disease
    Joseph H. Antin, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
  • A Phase II Trial to Compare Allogeneic Transplant Vs. Standard of Care for Severe Sickle Cell Disease: Blood and Marrow Transplant Clinical Trials Network (BMT CTN) Pr...
    Joseph H. Antin, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
  • Join now to see all

Lectures

  • Allogeneic Stem Cell Transplantation Provides Durable Remission in Patients with Primary Mediastinal Large B-Cell Lymphoma 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018

Press Mentions

  • Dana-Farber Researchers to Showcase Pivotal Transplant and Cellular Therapy Findings at 2025 Tandem Meetings
    Dana-Farber Researchers to Showcase Pivotal Transplant and Cellular Therapy Findings at 2025 Tandem MeetingsFebruary 12th, 2025
  • Dana-Farber Researchers to Present Key Transplant and Cellular Therapy Studies at 2025 Tandem Meetings
    Dana-Farber Researchers to Present Key Transplant and Cellular Therapy Studies at 2025 Tandem MeetingsFebruary 12th, 2025
  • ASBMT News
    ASBMT NewsOctober 13th, 2018
  • Join now to see all

Grant Support

  • A Randomized Trial Of Tac/Mtx/Bortezomib VS Tac/Mtxplacebo In Allogeneic HSCTNational Heart, Lung, And Blood Institute2011
  • Novel Approaches To Graft-Versus-Host Disease PreventionNational Cancer Institute2009–2011
  • Mechanisms Of GVHDNational Cancer Institute2009–2011
  • Administrative CoreNational Cancer Institute2009–2011
  • Random Trial Of CD8 T-Cell Depletion In PBSC TransplantationNational Heart, Lung, And Blood Institute2006–2010
  • Novel Approaches To Ghvd PreventionNational Heart, Lung, And Blood Institute2007
  • Mechanisms Of GVHDNational Heart, Lung, And Blood Institute2003–2007
  • Randomized Trial Of CD8 T-Cell Depletion In PBSC Transp*National Heart, Lung, And Blood Institute2001–2005
  • Use Of Unrelated Donors For Bone Marrow TransplantationNational Center For Research Resources1997–1999
  • Phlebotomy For Research Studies After Marrow TransplantationNational Center For Research Resources1997–1999
  • Core--Clinical Bone Marrow Transplant ProgramNational Cancer Institute1997
  • Novel Therapy For Chronic Myelogenous LeukemiaNational Cancer Institute1993–1996

Professional Memberships

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: